Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020

SELL
$26.16 - $63.5 $523 - $1,270
-20 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$46.96 - $61.67 $939 - $1,233
20 New
20 $2,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Ranch Capital Advisors Inc. Portfolio

Follow Ranch Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.